Allopurinol

Allopurinol

Cat Number
API315300
CAS Number
315-30-0

For research use only. We do not supply to patients.

For pharmaceutical-grade products or other inquiries, please contact our experts.

CAS Number
315-30-0
EINECS
206-250-9
Storage
Store at room temperature
Synonyms
Zyloric; Suspendol; Takanarumin; Allopur; Bloxanth; Uriprim; Xanturat
Molecular Formula
C5H4N4O
Molecular Weight
136.11
Smiles
C1=NNC2=C1C(=O)NC=N2
Appearance
White to off-white solid
Melting Point
350°C
Boiling Point
290.8°C at 760 mmHg
Relative Density
1.89
General Description
Allopurinol is a synthetic xanthine oxidase inhibitor, structurally related to hypoxanthine, with the chemical formula 1H-pyrazolo[3,4-d]pyrimidin-4-ol. It is a white to off-white crystalline powder that is practically insoluble in water. The molecule is a purine analogue that acts as a competitive inhibitor of the enzyme xanthine oxidase.
Mechanism of Action
Allopurinol inhibits the enzyme xanthine oxidase, which is responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid. By blocking this enzyme, the drug reduces the production of uric acid, lowering serum and urinary urate levels. The active metabolite, oxypurinol, is also a potent inhibitor of xanthine oxidase, contributing to the drug's long duration of action.
Application
Allopurinol is indicated for the management of hyperuricemia in patients with gout, including the prevention of acute gout attacks and the treatment of tophi. It is also used for the prevention of uric acid nephropathy in patients with leukemia and lymphoma undergoing chemotherapy.

In Otsuka Long-Evans Tokushima Fatty rats, high-fructose diet increased body weight, epididymal fat, uric acid, cholesterol, triglycerides, hepatic enzymes, and NAFLD activity score. Allopurinol treatment reduced hepatic steatosis, epididymal fat, serum uric acid, HOMA-IR, and hepatic enzymes. It downregulated lipogenic genes, upregulated lipid oxidation genes, reduced pro-inflammatory cytokines, and decreased ER stress proteins. Allopurinol ameliorates fructose-induced hepatic steatosis through lipid metabolism, inflammation, and ER stress modulation, suggesting a role for uric acid in NAFLD.

Fig. 1 Effects of HFrD and allopurinol treatment on glucose tolerance test. (Cho IJ, <i>et al</i>., 2021) Fig. 1 Effects of HFrD and allopurinol treatment on glucose tolerance test. (Cho IJ, et al., 2021)

References

  1. Cho IJ, et al. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. Sci Rep. 2021;11(1):9894.

In a phase 2b trial (861 patients with CKD and hyperuricemia), verinurad (a URAT1 inhibitor) combined with allopurinol did not reduce urinary albumin/creatinine ratio or eGFR decline compared to allopurinol alone or placebo at 34 or 60 weeks. Serum urate was dose‑dependently lowered. Adverse events were balanced. Verinurad does not provide renal benefit beyond urate lowering in this population.

Fig. 2 Correlation between change from baseline in UACR and serum urate for the different dose groups. (Heerspink HJL, <i>et al</i>., 2024) Fig. 2 Correlation between change from baseline in UACR and serum urate for the different dose groups. (Heerspink HJL, et al., 2024)

References

  1. Heerspink HJL, et al. Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial. J Am Soc Nephrol. 2024;35(5):594-606.

Does Allopurinol require protection from light during long-term storage?

Yes, it is photosensitive. UV exposure can cause photodegradation and discoloration. Store in light-resistant containers, preferably amber glass.

What is the recommended storage temperature for Allopurinol?

Store at controlled room temperature (15–25°C). Avoid excessive heat above 30°C, which can accelerate degradation.

Is Allopurinol stable in tablet and injectable formulations?

Tablets are stable when protected from moisture. Injectable solutions are stable when protected from light and stored at room temperature.

How is the impurity oxypurinol (an oxidative degradation product) monitored?

This degradation product is specifically quantified using a stability-indicating HPLC method, ensuring it remains within pharmacopoeial limits.
You Might Also Like
Dotinurad
Dotinurad

Cat NO.: API1285572511
CAS NO.: 1285572-51-1

View Details
Diclofenac Potassium
Diclofenac Potassium

Cat NO.: API15307810
CAS NO.: 15307-81-0

View Details
Allopurinol Sodium
Allopurinol Sodium

Cat NO.: API17795210
CAS NO.: 17795-21-0

View Details
Febuxostat
Febuxostat

Cat NO.: API144060537
CAS NO.: 144060-53-7

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)

All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.

Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.


WhatsAPP
Top